Clinical Trial Update: Dimethyl Fumarate in Adrenomyeloneuropathy [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update indicating dimethyl fumarate is being tested for adrenomyeloneuropathy without cerebral involvement, currently recruiting for Phase 2/Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenomyeloneuropathy

Drugs mentioned

• Dimethyl fumarate (Dimethyl fumarate)

Snippet

Sponsor: Pujol, Aurora, M.D. | Conditions: Adrenomyeloneuropathy Without Cerebral Involvement | Phase 2, Phase 3 | Status: RECRUITING